Healthy Aging Health Center
Attend Religious Services, Live Longer
Nov. 25, 2008 -- Going to church -- or any kind of religious service -- may prolong your life.
A new study shows that older women who regularly attend religious services reduce their risk of death by 20%. The study was published in Psychology and Health.
Researchers from Yeshiva University's Albert Einstein College of Medicine grouped all religions together, looking only at whether the women attended services regularly and whether those services brought them comfort.
Organized religion creates a social network with regular routines, which is known to enhance well-being. However, even when researchers adjusted for that factor, the women going to services were still less likely to die.
"Interestingly, the protection against mortality provided by religion cannot be entirely explained by expected factors that include enhanced social support of friends or family, lifestyle choices, and reduced smoking and alcohol consumption," lead author and clinical assistant professor of psychology Eliezer Schnall says in a news release. "There is something here that we don't quite understand. It is always possible that some unknown or unmeasured factors confounded these results."
Researchers evaluated 92,395 postmenopausal women participating in the Women's Health Initiative Observational Study, a national, multi-ethnic, long-term study aimed at addressing women's health issues funded by the National Institutes of Health. The women, all between the ages of 50 and 79, answered questions about their behaviors, health, and religious practices.
Researchers followed participants for an average of 7.7 years and made adjustments for known risk factors, such as age and health history, when evaluating risk of death. They found that women attending religious services at least once per week showed a 20% mortality risk reduction compared to those not attending services at all.
In addition to looking at mortality broadly, researchers examined the risk of death from cardiovascular disease. They did not find that religion had an impact on the women's risk of death by this particular cause.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRIPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


